ClariVest Asset Management’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,248
Closed -$529K 761
2021
Q4
$529K Sell
6,248
-411
-6% -$41.8K 0.02% 426
2021
Q3
$638K Sell
6,659
-231
-3% -$21.3K 0.02% 400
2021
Q2
$641K Buy
6,890
+18
+0.3% +$1.73K 0.02% 392
2021
Q1
$779K Sell
6,872
-400
-6% -$54.6K 0.03% 327
2020
Q4
$1.07M Sell
7,272
-9,827
-57% -$1.1M 0.04% 268
2020
Q3
$1.01M Buy
17,099
+5,850
+52% +$294K 0.03% 299
2020
Q2
$609K Sell
11,249
-5,058
-31% -$285K 0.02% 376
2020
Q1
$778K Sell
16,307
-68
-0.4% -$4.08K 0.02% 336
2019
Q4
$1.18M Buy
+16,375
New +$596K 0.03% 333

Other funds holding KOD

ClariVest Asset Management's KOD Position: Q1 2022 in Review

ClariVest Asset Management sold out of Kodiak Sciences (KOD) in Q1 2022, closing a stake of 6,248 shares — an estimated $529K sold.

ClariVest Asset Management first reported a position in KOD in Q4 2019 and held it in 9 quarters. The position peaked at $1.18M in Q4 2019. 142 funds tracked by Wall St. Rank hold KOD as of Q1 2022.

  • ClariVest Asset Management reported no remaining Kodiak Sciences position as of Q1 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 6,248 Kodiak Sciences shares in Q1 2022, an estimated $529K.
  • ClariVest Asset Management first reported a position in Kodiak Sciences in Q4 2019 and held it in 9 quarters.
  • ClariVest Asset Management's Kodiak Sciences position peaked at $1.18M in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2022.

Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.